Skip to main content
Log in

Pharmacological, Therapeutic and Toxicological Properties of Furazolidone: Some Recent Research

  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

Some of the recent publications on the pharmacological, therapeutic and toxicological properties of the antimicrobial agent furazolidone (FZ) are briefly reviewed. In animals, most of the recently published papers focus on (1) the methodology of measuring the residues of the drug and its metabolites in edible tissues; (2) the carcinogenicity and genotoxicity of FZ; (3) the cellular and molecular basis of FZ-induced cardiomyopthy, and the action of different cardioprotectant drugs thereon; and (4) hormonal effects. In humans, the use of FZ as an anti-ulcer drug and in controlling infectious diseases, especially opportunistic infections in AIDS patients, is described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Ali,-B.H., 1983. Some pharmacological and toxicological properties of furazolidone in man and animals. Veterinary Research Communications, 6, 1–11

    Google Scholar 

  • Ali, B.H., 1989. Pharmacology and toxicity of furazolidone in man and animals: some recent research. General Pharmacology, 20, 557–563

    Google Scholar 

  • Ali, B.H., 1991. Effect of nitrofurans on duodenal ulceration induced by cysteamine or indomethacin. Pharmacology, 42, 49–53

    Google Scholar 

  • Ali, B.H., 1992. Effect of furazolidone on tissue sulphydryl groups, ascorbic acid, and lipid peroxide levels in the rat, and the influence of dimethylsulphoxide thereon. Pharmacological Research, 25, 247–254

    Google Scholar 

  • Ali, B.H., Homeida, A.M. and Knifton, A., 1984. The effect of furazolidone on fertility of male chickens. Comparative Biochemistry and Physiology, 78C, 43–47

    Google Scholar 

  • Ali, B.H., Bashir, A.K. and Tanira, M.O., 1996. The effect of furazolidone and furaltadone on drug metabolism in rats. European Journal of Drug Metabolism and Pharmacokinetics, 21, 327–332

    Google Scholar 

  • Amin, V., Patwari, A.K., Kumar, G., Anand, V.K., Diwan, N. and Peshin, S., 1995. Clinical profile of cholera in young children-a hospital based report. Indian Pediatrics, 32, 755–761

    Google Scholar 

  • Andrabi, S.M., Ahmad, M.M. and Shahab, M., 1998. Furazolidone treatment suppresses pubertal testosterone secretion in male broiler breeder birds. Veterinary and Human Toxicology, 40, 321–325

    Google Scholar 

  • Angelini, N.M., Rampini, O. D. and Mugica, H., 1997. Liquid chromatographic determination of nitrofuran residues in bovine muscle tissues. Journal of the Association of Offcial Analytical Chemists, 80, 481–485

    Google Scholar 

  • Arbid, M.S., el Habbak, M.M. and Hanafy, M.S., 1990. Toxicological and biological studies on Japanese quails fed graded levels of furazolidone. Acta Veterinaria Hungarica, 38, 271–279

    Google Scholar 

  • Basak, J., 1995. Inter-strand cross-linking of vibrio cholera DNA induced by furazolidone: a quantitative assay by four simple methods. Mutation Research, 327, 5–15

    Google Scholar 

  • Bartlet, A.L. and Khan, F.H., 1990. Effects of nitrofurans on adrenal cortical tissue in chickens. Journal of Veterinary Pharmacology and Therapeutics, 13, 206–216

    Google Scholar 

  • Bartlet, A.L., Harvey, S. and Klandorf, H., 1990. Contrasting e¡ects of nitrofurans on plasma corticosterone in chickens following administration as a bolus or diet additive. Journal of Veterinary Pharmacology and Therapeutics, 13, 261–269

    Google Scholar 

  • Burge, S. and Bransbury, A., 1994. Allergic contact dermatitis due to furazolidone in piglet medication. Contact Dermatitis, 31, 199–200

    Google Scholar 

  • Bychkova, N., Petrov, A.V., Perederii, V.G. and Lurchenko, E.S., 1993. The immunological aspects of the antibacterial therapy of peptic ulcer patients. Lik Sprava, 10–12, 79–81

    Google Scholar 

  • Chapados, R.A., Gruver, E.J., Ingwall, J.S., Marsh, J.D. and Gwathmey, J.K., 1992. Chronic administra-tion of cardiovascular drugs: altered energetics and transmembrane signaling. American Journal of Physiology, 263, H1576-H1586

    Google Scholar 

  • Conney, A.H., 1967. Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews, 14, 727–741

    Google Scholar 

  • Czarnecki, C.M., 1984. Review of cardiomyopathy in turkeys. Comparative Biochemistry and Physiology, 77A, 591–598

    Google Scholar 

  • Czarnecki, C.M., 1990. Effect of including lasalocid or monensin singly or in combination with furazolidone on the growth and feed consumption of turkey poults. Research in Veterinary Science, 49, 256–260

    Google Scholar 

  • Czarnecki, C.M., 1991. Influence of exogenous T4 on body weight, feed consumption, T4 levels, and myocardial glycogen in furazolidone-fed turkey poults. Avian Diseases, 35, 930–936

    Google Scholar 

  • Czeczot, H. and Kobierska-Szeliga, M., 1995. The effect of nitrofurazone and furazolidone on induction of cytochrome P-450 in the CYPIA test. Roczniki Panstwowego Zakladv Higieny, 46, 397–405

    Google Scholar 

  • De Angelis, I., Vicentini, O., Brambilla, G., Stammati, A. and Zucco, F., 1998. Characterization of furazolidone apical-related e¡ects to human polarized intestinal cell. Toxicology and Applied Pharma-cology, 152, 119–127

    Google Scholar 

  • De Groot, A.C. and Conemans, J.M., 1990. Contact allergy to furazolidone. Contact Dermatitis, 22, 202–205

    Google Scholar 

  • Diaz, G., Cabanillas, G., Valenzuela, A., Correa, C.A. and Salins, F., 1997. Determination of nitrofur-antoin, furazolidone and furaltadone in milk by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography, 764, 234–238

    Google Scholar 

  • Dionisio, D., Sterrantino, G., Meli, M., Trotta, M., Milo, D. and Leoncini, F., 1995. Use of furazolidone for the treatment of microsporidiosis due to Enterocytozoon bieneusi in patients with AIDS. Recent Progress in Medicine, 86, 394–397

    Google Scholar 

  • Dionisino, D., Manneschi, L., Lollo, S.D., Orsi, A., Sterrantino, G., Meli, M., Gabbrielli, M., Tani, A., Papucci, A and Leoncini, F., 1997. Enterocytozoon bieneusi in AIDS: symptomatic relief and parasite changes after furazolidone. Journal of Clinical Pathology, 50, 472–476

    Google Scholar 

  • Dixon, R.J., Arzey, G.G. and Nicholls, P.J., 1992. Production, hatchability and fertility of eggs from breeding Japanese quail fed diets containing furazolidone. British Poultry Science, 33, 835–845

    Google Scholar 

  • Dutta, P., Rasaily, R., Saha, M.R., Mitra, U., Manna, B., Chakraborty, S. and Mukherejee, A., 1993. Randomized clinical trial of furazolidone for typhoid fever in children. Scandanavian Journal of Gastroenterology, 28, 168–172

    Google Scholar 

  • Finnie, J.W., 1992. Furazolidone toxicity in calves. Australian Veterinary Journal, 69, 21

    Google Scholar 

  • Gajewska, J., Szczypka, M., Tudek, B. and Szymczyk, T., 1990. Studies on the e¡ect of ascorbic acid and selenium on the genotoxicity of nitrofurans: nitrofurazone and furazolidone. Mutation Research, 232, 191–197

    Google Scholar 

  • Genao, A., Seth, K., Schmidt, U., Carles, M. and Gwathmey, J.K., 1996. Dilated cardiomyopathy in turkeys: an animal model for the study of human heart failure. Laboratory Animal Science, 46, 399–404.

    Google Scholar 

  • Glass, M.G, Fuleihan, F., Liao, R., Lincoff, A.M., Chapados, R., Hamlin, R., Apstein, C.S., Allen, P.D., Ingwall, J.S., Hajjar, R.J. et al., 1993. Differences in cardioprotective efficacy of adrenergic receptor antagonists and Ca2+ channel antagonists in an animal model of dilated cardiomyopathy. Effects on gross morphology, global cardiac function, and twitch force. Circulation Research, 73, 1077–1089

    Google Scholar 

  • Goodwin, C.S., 1997. Antimicrobial treatment of Helicobacter pylori infection. Clinical and Infectious Diseases, 25, 1023–1026

    Google Scholar 

  • Gwathmey, J.K., 1991. Morphological changes associated with furazolidone-induced cardiomyopathy: effects of digoxin and propranolol. Journal of Comparative Pathology, 104, 33–45

    Google Scholar 

  • Hajjar, R.J., Liao, R., Young, J.B., Fuleihan, F., Glass, M.G. and Gwathmey, J.K., 1993. Pathophysiology and biochemical characterization of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy. Cardiovascular Research, 27, 2212–2221

    Google Scholar 

  • Hoogenboom, L.A., Tomassini, O., Oorsprong, M.B. and Kuiper, H.A., 1991a. Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone. Food and Chemical Toxicology, 29, 185–191

    Google Scholar 

  • Hoogenboom, L.A., van Kammen, M., Berghmans, M., Koeman, J.H. and Kuiper, H.A., 1991b. The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detection. Food and Chemical Toxicology, 29, 321–328

    Google Scholar 

  • Hoogenboom, L.A., Berghmans, M.C., Polman, T.H., Parker, R. and Shaw, I.C., 1992. Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side-chain from liver, kidney, and muscle tissues from pigs. Food Additives and Contamination, 9, 623–630

    Google Scholar 

  • Horne, E., Cadogan, A., O'Keeffe, M. and Hoogenboom, L.A., 1996. Analysis of protein-bound metabolites of furazolidone and furaltadone in pig liver by high-performance liquid chromatography and liquid chromatography-mass spectrometry. Analyst, 121, 1463–1468

    Google Scholar 

  • Islam, N., Khan, M.Z., Zaman, Q. and Muhammad, G., 1995. Effect of concurrent feeding of furazolidone and sodium chloride upon some clinical, pathological and cardiac morphometric parameters in broiler chicks. Journal of Veterinary Medicine A, 42, 91–98

    Google Scholar 

  • Jager, L.P., de Graff, G.J., Widjaja-Greefkes, H.C., Accord-Burleson, C.C.F., van Den Dungen, H.M. and Baars, A.J., 1994. Effects of feed additives and veterinary drugs on aldosterone production and release by porcine adrenal cells in vitro. Journal of Veterinary Pharmacology and Therapeutics, 17, 175–185

    Google Scholar 

  • Jager, L.P., de Graff, G.F. and Widjaja-Greefkes, H.C., 1997. Differential e¡ects of nitrofurans on the production/release of steroid hormones by porcine adrenocortical cells in vitro. European Journal of Pharmacology, 331, 325–331

    Google Scholar 

  • Khan, Z.M., Zaman, Q., Islam, N. and Muhammad, G., 1995. Furazolidone toxicosis in young broiler chicks: morphometric and pathological observations on heart and testes. Veterinary and Human Toxicology, 37, 314–317

    Google Scholar 

  • Klee, S. and Ungemach, F.R., 1992. In vitro studies of intestinal absorption and biotransformation of furazolidone. Deutsche TierartztlicheWochenschrift, 99, 398–401

    Google Scholar 

  • Kumar, A.S., Legori, M., Sathy, N. and Mathew, R., 1995. Furazolidone in typhoid fever-correlation of clinical e¤cacy with serum bacterial activity. Indian Pediatrician, 32, 533–538

    Google Scholar 

  • Lax, D. and Kukolich, S.G., 1992. Generation of furazolidone radical anion and its inhibition by glutathione. Biochemistry, Medicine and Metabolic Biology, 48, 56–63

    Google Scholar 

  • Lax, D., Holman, R.T., Johnson, S.B., Zhang, S.L., Li,Y., Noren, G.R., Stely, N.A. and Einzig, S., 1994a. Myocardial lipid composition in turkeys with dilated cardiomyopathy. Cardiovascular Research, 28, 407–413

    Google Scholar 

  • Lax, D., Martinez-Zaguilan, R. and Gillies, R.J., 1994b. Furazolidone increases thapsigarin-sensitive Ca2+-ATP ase in chick cardiac monocytes. American Journal of Physiology, 267, H734–741

    Google Scholar 

  • Liao, R., Nasimben, L., Friedrich, J., Gwathmey, J.K. and Ingwall, J.S., 1996. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circulation Research, 78, 893–902

    Google Scholar 

  • Ludewig, T.H., Gutte, G. and Zimmermann, H., 1995. Histomorphometric and histological investigations on the morphometric e¡ects of furazolidone on the spermatogenesis in mature rats. Anatomy, Histology and Embryology, 24, 7–12

    Google Scholar 

  • McCallum, T., Badylak, S.F., van Vleet, J.F. and Reed, W.M., 1989. Furazolidone-induced injury in the isolated perfused chicken heart. American Journal of Veterinary Research, 50, 1183–1185

    Google Scholar 

  • McCracken, R.J. and Kennedy, D.G., 1997a. Determination of furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues using liquid chromatography-thermospray mass spectrometry and the occurrence of residues in pigs produced in Northern Ireland. Journal of Chromatography and Biomedical Sciences Application, 691, 87–94

    Google Scholar 

  • McCracken, R.J. and Kennedy, D.G., 1997b. The bioavailability of residues of the furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues and the effect of cooking upon residue concentrations. Food Additives and Contamination, 14, 507–513

    Google Scholar 

  • McCracken, R.J., McCoy, M.A. and Kennedy, D.G., 1997. The prevalence and possible causes of bound and extractable residues of the furazolidone metabolite 3-amino-oxazolidinone in porcine tissues. Food Additives and Contamination, 14, 287–294

    Google Scholar 

  • Narcisi, E.M. and Secor, W.E., 1996. In vitro e¡ect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrobial Agents and Chemotherapy, 40, 1121–1125

    Google Scholar 

  • Nouws, J.F. and Laurensen, J.H., 1990. Postmortal degradation of furazolidone and furaltadone in edible tissues of calves. Veterinary Quarterly, 12, 56–59

    Google Scholar 

  • O'Brien, P.J., Shen, H.,W eiler, J.E., Mirsalimi, S.M. and Julian, R.J., 1991. Myocardial calcium cycling defect in furazolidone cardiomyopathy. Canadian Journal of Physiology Pharmacology, 69, 1833–1840

    Google Scholar 

  • O'Brien, P.J., O'Grady, M., McCutcheon, L., Shen, H., Nowack, L., Horne, R.D., Mirsalimi, S.M., Julian, R.J., Grima, E.A., Moe, G.W. et al., 1992. Myocardial myoglobin deficiency in various animal models of congestive heart failure. Journal of Molecular and Cell Cardiology, 24, 721–730

    Google Scholar 

  • O'Brien, P.J., O'Grady, M., Lumsden, J.H., Holmberg, D.L., Shen, H., Weiler, J.E., Horn, S., Mirsalami, S.M. and Julian, R.J., 1993. Clinical pathologic pro¢les of dogs and turkeys with congestive heart failure, either noninduced or induced by rapid ventricular pacing, and turkeys with furazolidone toxicosis. American Journal of Veterinary Research, 54, 60–68

    Google Scholar 

  • Pang, C.Y., Phillips, G.D. and Campbell, L.D., 1979. The toxic effects of saline drinking on young turkey poults. British Poultry Science, 20, 1–7

    Google Scholar 

  • Plakas, S.M., el Said, K.R. and Stehly, G.R., 1994. Furazolidone disposition after intravascular and oral dosing in the channel catfish. Xenobiotica, 24, 1095–1105

    Google Scholar 

  • Rabbani, G.H., Butler, T., Shahier, M., Muzumdar, R. and Islam, M.R., 1991. Eficacy of a single dose of furazolidone for treatment of cholera in children. Antimicrobial Agents and Chemotherapy, 35, 1864–1867

    Google Scholar 

  • Rupp, H.S., Munns, R.K., Long, A.R. and Plakas, S.M., 1994. Simultaneous determination of nitrofur-azone, nitrofurantoin, and furazolidone in channel catfish muscle tissue by liquid chromatography. Journal of the Association of Official Analytical Chemists, 77, 344–350

    Google Scholar 

  • Sas, B., 1993. Contribution to the pathobiochemistry of furazolidone-induced oxidative toxicity in chickens. Acta Veterinaria Hungarica, 41, 103–121

    Google Scholar 

  • Sasaki, N., 1994. Effects of furazolidone on duration of righting re£ex loss induced with hexobarbital and zoxazolamine in the rat. Journal of Veterinary Medical Services, 56, 667–670

    Google Scholar 

  • Segura, A.M., Guttierrez, O., Otero,W., Angel, A., Genta, R.M. and Graham, D.Y., 1997. Furazolidone, amoxycillin, bismuth triple therapy for Helicobater pylori infection. Alimentary Pharmacology and Therapeutics, 11, 529–532

    Google Scholar 

  • Siddique, M., Khan, M.Z. and Muhammad, G., 1996. Reversibility of furazolidone-induced changes in testes and secondary sex characters of White Leghorn cockerels. Veterinary and Human Toxicology, 38, 413–417

    Google Scholar 

  • Sidorov,V. and Luders, H., 1971. Untersuchunge des Plasma corticosteronspiegeles von kuken nach oraler Applikation von Furazolidon. Deutsche TierarztlicheWochenschrift, 78, 375–378

    Google Scholar 

  • Stroo, W.E. and Schaffer, S.W., 1989. Furazolidone-enhanced production of free radicals by avian cardiac and hepatic microsomal membranes. Toxicology and Applied Pharmacology, 98, 81–86

    Google Scholar 

  • Tamayo-Sanchez, L., Ruiz-Maldonado, R. and Lateraz, A., 1997. Acute annular urticaria in infants and children. Pediatric Dermatology, 14, 231–234

    Google Scholar 

  • Tatsuta, M., Iishi, H., Baba, M. and Taniguchi, H., 1991. Attenuating effect of the monoamine oxidase inhibitor furazolidone on the anti-carcinogenetic effect of cysteamine on gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. International Journal of Cancer, 48, 605–608

    Google Scholar 

  • Taylor, J.D., Gibson, J.A. and Yeates, C.E.F., 1991. Furazolidone toxicity in dairy calves. Australian Veterinary Journal, 68, 182–183

    Google Scholar 

  • Ullah, H., Khan, M.Z., Muhammad, G. and Norrani, S.A., 1998. Furazolidone toxicosis in female Japanese quail: pathomorphological changes in reproductive tract and reversibility of the induced changes.Veterinary and Human Toxicology, 40, 212–215

    Google Scholar 

  • Van Zwet, A.A., Thijis, J.C., van derWouden, E.J. and Kooy, A., 1997. Low cure rate of Helicobacter pylori infection with omeperazole and furazolidone dual therapy for one week. Alimentary Pharmacology and Therapeutics, 11, 533–535

    Google Scholar 

  • Vroomen, L.H.M., Berghmans, M.C., van Bladeren, P.J., Groten, J.P., Wissink, C.J. and Kuiper, H.A., 1990. In vivo and in vitro metabolic studies of furazolidone: a risk evaluation. DrugMetabolism Reviews, 22, 663–676

    Google Scholar 

  • Walzer, P.D., Kim, C.K., Foy, J. and Zhang, J., 1991. Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy, 35, 158–163

    Google Scholar 

  • Webb, D.M. and Van Vleet, J.F., 1991. Early clinical and morphologic alterations in the pathogenesis of furazolidone-induced toxicosis in ducklings. American Journal of Veterinary Research, 52, 1531–1536

    Google Scholar 

  • Webb, D.M., De Nicola, D.B. and Van Vleet, J.F., 1991. Serum chemistry alterations, including creatine kinase isoenzymes, in furazolidone toxicosis of ducklings: preliminary findings. Avian Diseases, 35, 662–667

    Google Scholar 

  • Zaman, Q., Khan, M.Z., Islam, N. and Muhammad, G., 1995. Experimental furazolidone toxicosis in broiler chicks. Acta Veterinaria Hungarica, 43, 359–367

    Google Scholar 

  • Zhang, Z.T. and Xing, L.P., 1988. Effect of furazolidone on gut catecholamines in cysteamine-induced ulcer in the rat. Scandinavian Journal of Gastroenterology, 23, 1020–1024

    Google Scholar 

  • Zheng, Z. and Wang, Y.B., 1992. Treatment of peptic ulcer with furazolidone. Journal of Gastroenterology and Hepatology, 7, 533–537

    Google Scholar 

  • Zimmermann, H., Gutte, G., Kern, M., Golbs, S. and Ludewig, T., 1993. Basic reproductive toxicological studies of the e¡ect of furazolidone on the hypothalamo-hypophyseo-gonadal axis of female rats. Deutsche TierartzlicheWochenschrift, 100, 91–94

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ali, B. Pharmacological, Therapeutic and Toxicological Properties of Furazolidone: Some Recent Research. Vet Res Commun 23, 343–360 (1999). https://doi.org/10.1023/A:1006333608012

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006333608012

Navigation